AUTL

Autolus Therapeutics plc

Healthcare · Biotechnology

$87.73 sample

-0.14 (-0.16%) 1D

Market cap

$416.3B

Price as of

2026-10-05

Latest filing

8-K · 2026-09-11

Alerts

8

Price$87.73 +17.19% 3M daily closessample

88.7171.09

2026-07-082026-07-302026-08-212026-09-112026-10-05

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 01INSInsider buy: EVP, Operations
Sep 28INSInsider buy: General Counsel
Sep 22INSInsider buy: General Counsel
Sep 11SECDEF 14A filed
Sep 04INSInsider sell: 10% owner
Aug 28INSInsider sell: 10% owner
Aug 19INSInsider buy: EVP, Operations
Aug 14INSInsider sell: Director

Sign up to see the real AUTL record →

Company facts

SEC EDGAR registration

Name: Autolus Therapeutics plc
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +34sample, -100 to +100
Reporting currency: USD

Who is positioning in AUTL

sample

Insiders: 29 insider transactions over 90 days, net selling, $200.7M
Congress: 5 members traded over 90 days
Institutions · 13F: 7 funds hold $4.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$25.5B +18.4% y/y

Q4 2024Q3 2026

Inventory$15.3B +9.5% y/y

Q4 2024Q3 2026

Accounts receivable$11.5B +10.4% y/y

Q4 2024Q3 2026

Total debt$31.1B +11.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $256.2B +4.8% 3M
Sample peer B: $48.2B -4.6% 3M
Sample peer C: $282.8B +14.5% 3M
Sample peer D: $401.8B +9.5% 3M
Sample peer E: $236.2B +7.0% 3M